SLC12A3 and prostate cancer: We used a mendelian randomization approach to examine the effect of long-term inhibition of the drug targets for ACE inhibitors (ACE; angiotensin-converting enzyme), β blockers (ADRB1; beta-1 adrenergic receptor), and thiazide diuretic agents (NCC; sodium-chloride symporter) on risk of overall and subtype-specific breast, colorectal, lung, and prostate cancer.